Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis

Matthew Schwede; Dimitrios Spentzos; Stefan Bentink; Oliver Hofmann; Benjamin Haibe-Kains; David Harrington; John Quackenbush; Aedín C. Culhane

doi:10.1371/journal.pone.0057799

Loading metrics

Open Access

Peer-reviewed

Research Article

Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis

Matthew Schwede,

Affiliation Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Dimitrios Spentzos,

Affiliation Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America
⨯
Stefan Bentink,

Affiliations Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Exosome Diagnostics GmbH, Martinsried, Germany
⨯
Oliver Hofmann,

Affiliation Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯
Benjamin Haibe-Kains,

Affiliations Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Integrative Systems Biology, Institut de recherches cliniques de Montréal, Montreal, Quebec, Canada
⨯
David Harrington,

Affiliations Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯
John Quackenbush,

Affiliations Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America, Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Aedín C. Culhane

* E-mail: aedin@jimmy.harvard.edu

Affiliations Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯

Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis

Matthew Schwede,
Dimitrios Spentzos,
Stefan Bentink,
Oliver Hofmann,
Benjamin Haibe-Kains,
David Harrington,
John Quackenbush,
Aedín C. Culhane

Published: March 11, 2013
https://doi.org/10.1371/journal.pone.0057799

Reader Comments (1)

Post a new comment on this article

0 Responses

20 Sep 2013
05:32 GMT
Most Recent

GEO key correction Posted by RAguirre-Gamboa on 20 Sep 2013 at 05:32 GMT

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Ovarian cancer
Is the Subject Area "Ovarian cancer" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Differentiated tumors
Is the Subject Area "Differentiated tumors" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Uterine cancer
Is the Subject Area "Uterine cancer" applicable to this article?

Thanks for your feedback.
Histology
Is the Subject Area "Histology" applicable to this article?

Thanks for your feedback.
Cancer stem cells
Is the Subject Area "Cancer stem cells" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.